MAKERSL logo

Makers Laboratories LTD.

MAKERSL·BSE·
₹201.05▼ -6.25 (-3.01%)
Market Cap123.31 Cr
PE Ratio50.39
Volume341
Day High - Low214.00 - 201.05
52W High-Low236.00 - 150.00

Makers Laboratories Ltd. (MAKERSL): company summary

The company's revenue grew 16.4% annually, but net profit fell 28.0% year-on-year.

Makers Laboratories Ltd. (MAKERSL) is a micro-cap Healthcare company valued at ₹123 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Makers Laboratories Ltd. last traded at ₹201.05, down 3.01% on the day.
Recent developments
On 2026-09-30, promoter holding remained at 61.27%, showing no significant change in ownership. The latest quarter results, ending 2026-06-30, showed a strong rebound in net profit, reflecting improved performance compared to the prior-year quarter.
Financial performance
The company's revenue grew 16.4% annually, but net profit fell 28.0% year-on-year. The latest quarter saw a sharp rise in net profit, up 256.6% compared to the same quarter a year earlier, while revenue rose 22.2%.
Valuation multiples
The stock trades at 50.4 times earnings, a premium to the Healthcare median of 32.0, 1.45 times book value.
Things to watch
Net profit margin narrowed 3.4 percentage points to 5.6%, indicating pressure on profitability. The stock is 11.8% below its 52-week high, suggesting a pullback from recent peak levels.
Where it stands
The company has shown strong growth in recent quarters, with net profit jumping 256.6% in the latest quarter. However, annual net profit fell 28.0%, and the net profit margin declined, signaling challenges in sustaining profitability. The stock is currently 11.8% below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.5/10
Weak
Fair Value
Sign in to see
ROE
3.22%
Weak
P/E
50.39x
Expensive
Debt / Equity
0.07
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹201.05
₹214.00
52W₹150.00
₹236.00
DocStoX take

Supported by growth (8.7) and momentum (6.3), but held back by valuation (0.0). Growth looks strong at 8.7, but that is offset by valuation at 0.0 and quality at 2.8. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.5
/10
Weak
Quality
Weak
ROE 3.2%
Valuation
Expensive
P/E 50.4×
Growth
Strong
Revenue +15.3% 5Y CAGR
Risk
Moderate
D/E 0.07
Momentum
Firm
59% of 52-week range

At a glance

Market Cap
₹123 Cr
52W High / Low
₹236 / ₹150
Dividend Yield
0.00%
Promoter Holding
61.27%
EPS (TTM)
₹3.99
Book Value
₹123.59

Key highlights

  • Profit compounding 51% a year
  • Low leverage — D/E 0.07
  • Revenue compounding 15% a year
  • Loss-making in some of the last 5 years
  • Valuation is weak (0.0/10)
3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

MAKERS LABORATORIES LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.